Actively Recruiting

Age: 18Years - 99Years
All Genders
Healthy Volunteers
ID00001352

Cryptococcosis in Previously Healthy Adults Study of Immune and Genetic Factors in Cryptococcal Infection

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-06-05

800

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Cryptococcosis is a fungal infection that mainly affects people with weakened immune systems, like those with AIDS or organ transplants, but about one-third of cases occur in individuals without known immune problems. This research focuses on understanding immune system defects and genetic factors that may make previously healthy adults susceptible to cryptococcosis. The study aims to explore the pathophysiology and immune responses in these patients, including genetic screening of their relatives and comparison with healthy volunteers. Participants include three groups: previously healthy adults diagnosed with cryptococcosis without known immune defects, their blood relatives, and healthy adult volunteers. Various samples such as blood, saliva, cerebrospinal fluid, eyebrow hair, and nail clippings will be collected. Patients will receive standard medical care and may receive corticosteroids or immunosuppressive treatments if inflammation causes neurological damage. Genetic and immunologic testing will be performed to identify immune abnormalities and genetic susceptibility. Participants will be closely monitored with various tests to understand disease progression and immune responses. Healthy volunteers and relatives will also undergo testing to serve as comparison groups. The study will measure clinical disease spectrum and investigate immunological and genetic mechanisms over 1 to 5 years. Participants may be seen frequently as needed to manage their condition, and samples will be stored for future research.

CONDITIONS

Brief Title

Fungal Infection Susceptibility

Who Can Participate

Age: 18Years - 99Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must have cryptococcosis confirmed by pathology, culture, or antigen testing
  • Patients must be over 18 years old
  • Patients must have a primary physician outside the NIH
  • Patients must agree to genetic testing and sample storage for research
  • Pregnant patients are allowed, but certain invasive tests will be avoided
  • Blood relatives must be genetic relatives of enrolled patients, over 18, agree to genetic testing, and allow sample storage
  • Healthy volunteers must be between 18 and 70 years old and allow sample storage
Not Eligible

You will not qualify if you...

  • Patients with HIV, cancer chemotherapy, certain malignancies, or monoclonal antibody therapy affecting immunity
  • Patients with conditions interfering with immune evaluation, e.g., Cushing's disease
  • Blood relatives with conditions interfering with immune system evaluation
  • Healthy volunteers with HIV, viral hepatitis, history of severe infections, IV drug use, high-risk HIV exposure, chemotherapy, immunosuppressants, malignancies, pregnancy, or history of heart, lung, kidney disease, or bleeding disorders
  • Any condition that may interfere with immune system evaluation as judged by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - Up to 5 years

Participants provide biological samples such as saliva, blood, eyebrow hair, cerebrospinal fluid (CSF), and nail clippings for immune and genetic testing.

Visits as needed over the course of the study

Monitoring

Duration - 1 to 5 years

Participants are observed over time to understand disease progression, immune response, and genetic factors related to cryptococcosis.

Visits as often as necessary for medical management and assessments

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

P

Peter R Williamson, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

Etiology, Pathogenesis, and Natural History of Idiopathic CD...

Idiopathic CD4+ Lymphocytopenia

Actively Recruiting

1 location

Evaluation of CrAg Screening With Enhanced Antifungal Therap...

Cryptococcal Meningitis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Benjamin J Park, Kathleen A Wannemuehler, Barbara J Marston...

https://pubmed.ncbi.nlm.nih.gov/19182676

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

John R Perfect, William E Dismukes, Francoise Dromer...

https://pubmed.ncbi.nlm.nih.gov/20047480

Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status.

Kyle D Brizendine, John W Baddley, Peter G Pappas

https://pubmed.ncbi.nlm.nih.gov/23555970

Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant.

Emily W Bratton, Nada El Husseini, Cody A Chastain...

https://pubmed.ncbi.nlm.nih.gov/22937064

Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.

Joseph Meletiadis, Thomas J Walsh, Eun Hwa Choi...

https://pubmed.ncbi.nlm.nih.gov/17710620